Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Supportive Care in Cancer
Published in: Supportive Care in Cancer 11/2013

01-11-2013 | Original Article

Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics

Authors: Josephine S. Kim, Kristy K. Ward, Nina R. Shah, Cheryl C. Saenz, Michael T. McHale, Steven C. Plaxe

Published in: Supportive Care in Cancer | Issue 11/2013

Login to get access

Abstract

Purpose

The purpose of the study was to determine if a diagnosis of ovarian cancer is independently associated with an increased risk of Clostridium difficile infection (CDI).

Methods

The University HealthSystem Consortium database was queried to perform a retrospective cohort study of women with and without ovarian cancer who were diagnosed with CDI. Inpatients undergoing total hysterectomy from 2008 to 2012 were studied. Ovarian cancer patients were compared to non-ovarian cancer patients to evaluate relative risk (RR) of CDI. Adjustment was made for known or suspected CDI risk factors to determine RR of CDI independent of these variables.

Results

In this study, 115,203 patients were included. CDI was reported in 0.80 % of ovarian cancer patients and in 0.31 % of non-ovarian cancer patients (RR = 2.50; 95 % confidence interval (CI) = 2.02 to 3.35). Stratification by age, presence of other comorbidities, or administration of antineoplastic drugs did not significantly modify the elevated risk associated with ovarian cancer. Significantly increased risk in ovarian cancer patients was no longer observed after controlling for broad-spectrum antibiotic administration (RR = 1.28, 95 % CI = 0.39 to 4.13). Compared to non-ovarian cancer patients, ovarian cancer patients were more frequently treated with broad-spectrum antibiotics, had a 39 % longer mean duration of therapy, and had 2.5-fold greater mean total exposure to broad-spectrum antibiotics.

Conclusions

After adjustment for antibiotic use, ovarian cancer patients are not at excess risk of CDI. Additional studies are needed to understand the patterns of broad-spectrum antibiotic prescription for ovarian cancer patients leading to increased exposure. If feasible, reduction of this exposure may decrease morbidity in this population.
Literature
1.
2.
Kyne L, Sougioultzis S, McFarland LV, Kelly CP (2002) Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea. Infect Control Hosp Epidemiol 23(11):653–659. doi:10.​1086/​501989 PubMedCrossRef
3.
4.
5.
Zerey M, Paton BL, Lincourt AE, Gersin KS, Kercher KW, Heniford BT (2007) The burden of Clostridium difficile in surgical patients in the United States. Surg Infect (Larchmt) 8(6):557–566. doi:10.​1089/​sur.​2006.​062 CrossRef
6.
7.
8.
Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ (2012) Time interval of increased risk for Clostridium difficile infection after exposure to antibiotics. J Antimicrob Chemother 67(3):742–748. doi:10.​1093/​jac/​dkr508 PubMedCrossRef
9.
Owens RC Jr, Donskey CJ, Gaynes RP, Loo VG, Muto CA (2008) Antimicrobial-associated risk factors for Clostridium difficile infection. Clin Infect Dis 46(Suppl 1):S19–31. doi:10.​1086/​521859 PubMedCrossRef
10.
Wistrom J, Norrby SR, Myhre EB, Eriksson S, Granstrom G, Lagergren L, Englund G, Nord CE, Svenungsson B (2001) Frequency of antibiotic-associated diarrhoea in 2462 antibiotic-treated hospitalized patients: a prospective study. J Antimicrob Chemother 47(1):43–50. doi:10.​1093/​jac/​47.​1.​43 PubMedCrossRef
11.
Dubberke ER, Reske KA, Yan Y, Olsen MA, McDonald LC, Fraser VJ (2007) Clostridium difficile-associated disease in a setting of endemicity: identification of novel risk factors. Clin Infect Dis 45(12):1543–1549. doi:10.​1086/​523582 PubMedCrossRef
12.
Emoto M, Kawarabayashi T, Hachisuga MD, Eguchi F, Shirakawa K (1996) Clostridium difficile colitis associated with cisplatin-based chemotherapy in ovarian cancer patients. Gynecol Oncol 61(3):369–372PubMedCrossRef
13.
Masciullo V, Mainenti S, Lorusso D, Margariti PA, Scambia G (2010) Lethal Clostridium difficile colitis associated with paclitaxel and carboplatin chemotherapy in ovarian carcinoma: case report and review of the literature. Obstet Gynecol Int 2010. doi:10.​1155/​2010/​74978
14.
15.
Carignan A, Allard C, Pepin J, Cossette B, Nault V, Valiquette L (2008) Risk of Clostridium difficile infection after perioperative antibacterial prophylaxis before and during an outbreak of infection due to a hypervirulent strain. Clin Infect Dis 46(12):1838–1843. doi:10.​1086/​588291 PubMedCrossRef
16.
Fowler S, Webber A, Cooper BS, Phimister A, Price K, Carter Y, Kibbler CC, Simpson AJ, Stone SP (2007) Successful use of feedback to improve antibiotic prescribing and reduce Clostridium difficile infection: a controlled interrupted time series. J Antimicrob Chemother 59(5):990–995. doi:10.​1093/​jac/​dkm014 PubMedCrossRef
17.
Talpaert MJ, Gopal Rao G, Cooper BS, Wade P (2011) Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother 66(9):2168–2174. doi:10.​1093/​jac/​dkr253 PubMedCrossRef
18.
Aldeyab MA, Kearney MP, Scott MG, Aldiab MA, Alahmadi YM, Darwish Elhajji FW, Magee FA, McElnay JC (2012) An evaluation of the impact of antibiotic stewardship on reducing the use of high-risk antibiotics and its effect on the incidence of Clostridium difficile infection in hospital settings. J Antimicrob Chemother 67(12):2988–2996. doi:10.​1093/​jac/​dks330 PubMedCrossRef
Metadata
Title
Excess risk of Clostridium difficile infection in ovarian cancer is related to exposure to broad-spectrum antibiotics
Authors
Josephine S. Kim
Kristy K. Ward
Nina R. Shah
Cheryl C. Saenz
Michael T. McHale
Steven C. Plaxe
Publication date
01-11-2013
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 11/2013
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-013-1888-2

Other articles of this Issue 11/2013

Supportive Care in Cancer 11/2013 Go to the issue

Review Article

Systematic review of basic oral care for the management of oral mucositis in cancer patients

Erratum

Erratum to: Development of a knowledge assessment tool for dermatotoxicity caused by inhibitors of epidermal growth factor receptor

Original Article

Risk of oral and gastrointestinal mucosal injury among patients receiving selected targeted agents: a meta-analysis

Original Article

Lower limb lymphedema in gynecological cancer survivors—effect on daily life functioning

Review Article

Systematic review of natural agents for the management of oral mucositis in cancer patients

Original Article

Psychometric properties of the Chinese version of Sexual Function after Gynecologic Illness Scale (SFAGIS)
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits